| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Dunlop A. Sinclair is a Director at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $6.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2020 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 25,000 | $54.67 | $1,366,713.26 | -4.4% | |
| Dec 7, 2020 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 25,000 | $50.59 | $1,264,853.82 | -2.9% | |
| Dec 20, 2019 | APLS Apellis Pharmaceuticals, Inc. | Director | Sell | 136,000 | $29.12 | $3,960,868.40 | -10.4% |